Onyx shares rise on reports it is exploring options

11/28/2011 | Bloomberg

Onyx Pharmaceuticals' stock price rose as sources said the biopharmaceutical firm is reviewing strategic alternatives, including the possibility of a sale of the company. Last month, Onyx ended a dispute with Bayer regarding cancer drug candidate regorafenib, and the companies amended a partnership for kidney cancer medicine Nexavar.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC